Search

everythinglearnresearchcommunity

for

Search:↓

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Gushen Shengfa pills and Wuling capsules are more effective for hair growth and sleep quality than the control treatment.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

Anti-EGFR therapy can cause skin issues, but FGF7 treatment might help.

Ebastine may help regrow hair in alopecia areata patients.

People with alopecia areata are more likely to have other immune-related conditions.

Regulatory T cells are essential for normal and improved wound healing in mice.

Allergen desensitization reduces hair loss severity in dust-mite allergic alopecia areata patients.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Dupilumab significantly improved a 5-year-old girl's prurigo nodularis without side effects.

Dupilumab users have a higher risk of developing alopecia areata.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

Fzd2 is important for skin and hair development through various signaling ways.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Dupilumab may worsen hair loss in patients with alopecia areata.

Itchy keloids on the chest are linked to more nerve fibers and substance P.

Alopecia areata may be linked to atopic diseases like eczema, asthma, and allergies.

IL-13 protein is much higher in the skin of atopic dermatitis patients than in healthy skin.

Dupilumab can both cause and treat alopecia areata, with many patients experiencing hair regrowth.